KR20040102766A - Cosmetic composition containing niosome with tranexamic acid and supercritical fluid extract of phellinus linteus - Google Patents

Cosmetic composition containing niosome with tranexamic acid and supercritical fluid extract of phellinus linteus Download PDF

Info

Publication number
KR20040102766A
KR20040102766A KR1020030034367A KR20030034367A KR20040102766A KR 20040102766 A KR20040102766 A KR 20040102766A KR 1020030034367 A KR1020030034367 A KR 1020030034367A KR 20030034367 A KR20030034367 A KR 20030034367A KR 20040102766 A KR20040102766 A KR 20040102766A
Authority
KR
South Korea
Prior art keywords
tranexamic acid
mushroom
extract
skin
supercritical
Prior art date
Application number
KR1020030034367A
Other languages
Korean (ko)
Inventor
홍진천
Original Assignee
나드리화장품주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 나드리화장품주식회사 filed Critical 나드리화장품주식회사
Priority to KR1020030034367A priority Critical patent/KR20040102766A/en
Publication of KR20040102766A publication Critical patent/KR20040102766A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE: Provided is a cosmetic composition containing niosome including tranexamic acid and the supercritical fluid extract of Phellinus linteus. Therefore, the composition increase collagen synthesis and skin elasticity to prevent skin wrinkles, and reduces melanogenesis to whiten the skin. CONSTITUTION: The cosmetic composition is characterized by containing 0.001-15 wt.% of niosome which includes 0.01-20.0 wt.% of the mixture of tranexamic acid and the supercritical fluid extract of Phellinus linteus in a mixing ratio of 1:0.1-10.0.

Description

트라넥삼산 및 상황버섯 초임계 추출물 함유 니오좀을 함유하는 화장료 조성물{COSMETIC COMPOSITION CONTAINING NIOSOME WITH TRANEXAMIC ACID AND SUPERCRITICAL FLUID EXTRACT OF PHELLINUS LINTEUS}COSMETIC COMPOSITION CONTAINING NIOSOME WITH TRANEXAMIC ACID AND SUPERCRITICAL FLUID EXTRACT OF PHELLINUS LINTEUS}

본 발명은, 트라넥삼산 및 상황버섯 초임계 추출물 함유하는 화장료 조성물에 관한 것으로, 구체적으로는 니오좀으로 안정화된 트라넥삼산 및 상황버섯 초임계 추출물을 함유하는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition containing a tranexamic acid and a super mushroom extract, and more particularly, to a cosmetic composition containing a stabilized niexome and a supercritical extract.

현대인의 피부는, 외부의 각종 유해환경 및 스트레스에 노출되어 다양한 손상을 받고 있으며, 나이가 듦에 따라 피부의 생리활성이 저하되고 손상된 피부의 회복속도가 느려지면서, 건조, 탄력저하, 주름형성 등의 다양한 피부노화 현상을 맞게 된다. 또한 태양광으로부터의 자외선 조사로 인해 피부내 색소침착에 의한 기미, 주근깨 등이 생성된다. 이에 대하여, 피부 노화, 색소 침착 등을 개선하기 위한 다양한 화장료 소재가 개발되고 있다.The skin of modern man is exposed to various harmful environment and stresses and suffers various damages. As he ages, the physiological activity of the skin decreases and the recovery rate of damaged skin is slowed down, and the dryness, decrease of elasticity, wrinkle formation, etc. Will meet various skin aging phenomena. In addition, the irradiation of ultraviolet rays from sunlight generates spots, freckles and the like due to pigmentation in the skin. On the other hand, various cosmetic materials for improving skin aging, pigmentation, etc. have been developed.

리포좀은 약물전달시스템에 이용되고 있는 리포좀의 특별한 한 종류로, 제약분야 뿐 만 아니라 화장품, 식품 등에도 널리 이용되는 있다. 이는 생리활성 성분을 깨어지지 않은 상태로 안정하게 전달할 수 있고, 생리활성 성분이 지용성이든수용성이든 모두 내포시킬 수 있다는 장점을 갖고 있다.Liposomes are a special kind of liposomes that are used in drug delivery systems, and are widely used not only in the pharmaceutical field but also in cosmetics and food. This has the advantage that the bioactive ingredient can be stably delivered in an unbroken state, and that the bioactive ingredient can be contained in both fat-soluble and water-soluble.

리포좀은 크게 다막리포좀(MLV:Multilamella vesicle)과 단막리포좀 (ULV:Unilamella vesicle)로 구분되고, ULV는 대단막리포좀(Large Unilamella vesicle)과 소단막리포좀(Small Uni lame lla vesicle)으로 나눌 수 있다. MLV는 그 크기가 400~3,500nm이고, 리포좀 안에 내포시킬 수 있는 양이 5~15%이다. LUV는 그 크기가 100~1,000nm이고, 리포좀 안에 내포시킬 수 있는 양이 36~65%이며, SLV는 그 크기가 20~50nm이고, 리포좀 안에 내포시킬 수 있는 양이 0.5~1.0%이다. 생리활성 물질을 내포시킬 수 있는 양은 LUV가 가장 많으나 불안정하고, SLV는 가장 안정하나 내포시킬 수 있는 양이 적다. 또한, 사람의 피부의 구조는 다막의 구조를 갖고 있어 MLV는 피부와 친화력이 있으나 크기가 너무 커 피부 침투가 어렵다.Liposomes are largely divided into MLV (Multilamella vesicle) and monolithic liposomes (ULV: Unilamella vesicle), and ULV can be divided into Large Unilamella vesicle and Small Uni lame lla vesicle. MLV is 400-3500 nm in size and 5-15% of the amount can be contained in liposomes. LUV has a size of 100-1,000 nm, 36-65% of the amount can be contained in liposomes, and SLV has a size of 20-50 nm, and 0.5-1.0% of the amount can be contained in liposomes. The amount of bioactive substances that can be contained is the most LUV but unstable, SLV is the most stable but the amount that can contain less. In addition, the structure of the human skin has a multi-layered structure, so MLV has affinity with the skin, but its size is so large that it is difficult to penetrate the skin.

이와 달리, 니오좀은 크기가 10~50nm 이며, 그 구성성분에 있어서, 인지질로 구성되는 리포좀과 달리, 세라마이드(Ceramide), 세레브로사이드(Cerebroside), 글리코리피드(Glycolipid), 스핑고미엘린(Sphingomyelin) 등과 같은 스핑고지질(Sphingolipid) 유도체를 사용하여 비히클(Vesicle)을 형성하고 이 비히클 안에 생리활성 성분을 내포시키게 된다.Niosome, on the other hand, has a size of 10-50 nm, and in its constituents, unlike liposomes consisting of phospholipids, ceramide, cerebromide, glycolipid, sphingomyelin Sphingolipid derivatives, such as), are used to form vehicles and to incorporate bioactive components in the vehicle.

상황 버섯(phellinus linteus)은 소나무 비늘 버섯과(Hymenochaetaceae)의 진흙버섯속(Phellinus Quel. em. lmaz)에 속하며, 우리나라에서는 목질 진흙버섯(Phellinus Linteus)을 지칭한다. 이 진흙버섯속에는 전세계 약 48종의 자연산 상황버섯이 보고되고 있으며, 우리나라에서는 녹슨진흙버섯(P.ferruginosus), 마른진흙버섯(P. gilvus), 말똥진흙버섯(P. igniarius), 가지진흙버섯(P. laevigatus), 벚나무진흙버섯(P. pomaceus), 찰진흙버섯(P. robustus), 전나무진흙버섯, 낙엽진흙버섯(P. pini) 등의 8종의 자연산 상황버섯이 존재한다.Phellinus linteus belongs to the Phellinus Quel. Em. Lmaz of the Hymenochaetaceae family and refers to the woody mud mushroom (Phellinus Linteus) in Korea. In this mud mushroom, about 48 kinds of natural situation mushrooms are reported around the world, and in Korea, rusty mud mushrooms (P.ferruginosus), dried mud mushrooms (P. gilvus), horse mud mushrooms (P. igniarius), and branch mud mushrooms ( There are eight kinds of natural situation mushrooms including P. laevigatus, P. pomaceus, P. robustus, fir mud and P. pini.

이러한 상황버섯은 항암효과, 면역강화기능, 종양저지효과 등의 약리효과를 가지며, 자궁출혈, 월경불순 등의 부인병 치료에도 효과가 있다고 알려져 있다(목질진흙 (상황)버섯의 면역활성 Korean journal of mycology Vol.26(1) pp.86-90, 1998 송치현. 상황버섯 자실체의 in vitro 및 in vivo 항암활성 Korean Journal of food science and technology Vol.32(2) pp.477-480, 2000 이영경. 고등균류 균사체의 면역조절 기능성에 관한 연구 Korean journal of mycology Vol.24(2) p.142-148, 1996 배만종).These situational mushrooms have pharmacological effects such as anticancer effect, immune enhancing function and tumor suppression effect, and are known to be effective in the treatment of gynecological diseases such as uterine bleeding and menstrual irregularities (Immune activity of woody mud (situation) mushroom) Vol.26 (1) pp.86-90, 1998 Song Chi-Hyun.In vitro and in vivo Anticancer Activity of Situation Mushroom Fruiting Body Korean Journal of food science and technology Vol.32 (2) pp.477-480, 2000 A study on the immunomodulatory function of mycelium Korean journal of mycology Vol.24 (2) p.142-148, 1996 Bae Bae Jong).

또한, 상황버섯 추출물에는 여러 종류의 당과 플라보노이드 성분, 섬유질, 이소플라본 등이 다량 함유되어 있어, 화장품으로 사용할 때 보습력과 피부노화 방지기능, 항산화 효과가 우수하고 특히 피부 미백효과 면에서 효과가 매우 우수하다고 보고되고 있다(배양 조건에 따른 상황 버섯의 다당류 생산 및 다당류 구성 변화 Korean journal of mycology Vol.23(4) pp.325-331, 1995 이재훈. 상황버섯속 자실체의 항산화 작용에 관한 연구 농업과학논문집 박사후 연수과정편 Vol.40 pp.51-56, 1998 정교순).In addition, the situation mushroom extract contains a large amount of various kinds of sugars, flavonoids, fiber, isoflavones, etc. When used as a cosmetic, it is excellent in moisturizing, anti-aging and anti-oxidant effects, especially in terms of skin whitening effect. Changes in Polysaccharide Production and Polysaccharide Composition of Situation Mushrooms According to Culture Conditions Journal of mycology Vol.23 (4) pp.325-331, 1995 Postdoctoral Training Course Vol.40 pp.51-56, 1998

이와 관련하여, 최근 의약품 및 화장품 분야에서 미백효과와 항산화 효과를 갖는 자연산 상황버섯 추출물 함유 제품이 개발되고 있으나, 이들 효과가 보다 탁월한 제품이 요구되고 있다.In this regard, in recent years, products containing natural situation mushroom extracts having a whitening effect and an antioxidant effect have been developed in the pharmaceutical and cosmetic fields, but products having more excellent effects are required.

한편, 트라넥삼산에 대해서는, 구강 내 창상 효과(Journal of Korean Asspcoiation of Oral and Maxillifacual Surgeons 1987 년 13 권 1 호  P217  ~ P233 이영석), 치주질환원인균과 구취유발원인균에 대한 항균 효과(Journal of the Korean Academy of Dental Health 1998 년 22 권 3 호  P205  ~ P214 문혁수), 섬유소용해 억제 효과(The Journal of Korean Society of Anesthesiologist 1996 년 31 권 5 호  P634  ~ P639 신치만), 피부 장벽기능 회복효과(J Invest Dermatol. 1997 Jul;109(1):84-90. Denda M), 피부 상처치유 증진 효과(Int J Oral Maxillofac Surg. 1988 Aug;17(4):275-6. Bjorlin G, Nilsson IM.) 등이 알려져 있으며, 항 혈액 응고제로 처리된 염소에서의 출혈량에 대한 비교 연구(Journal of Korean Asspcoiation of Oral and Maxillifacual Surgeons 1987 년 13 권 1 호  P207  ~ P216 오세형. Invest Clin. 1998 Jun;39(2):77-83. Spanish Bernardoni-Socorro C) 등이 연구 진행되었다. 트라넥삼산 관련 특허 문헌으로는, 미리 형성된 겔 시트(국내출원 공개 제 1020027000213호), 시트형 디바이스(국내출원 공개 제 1020027000208호), 고분자 나노입자를 이용한 경피흡수제 및 이를 함유한 외용제 조성물(국내출원 공개 제 1020010019869호), 피부보호 활성성분을 침적 시키는 피부 및 모발을 위한 세정 제품(국내출원 공개 제 1020007011848호), 다중 에멀젼법에 의한 서방출성 미립구의 제조방법(국내출원 공개 제 1020000036178호), 트라넥삼산 유도체 및 그것을 배합한 피부외용제(국내출원 공개 제 1019947000952호) 등이 있다.On the other hand, for tranexamic acid, it was reported that the intraoral wound effect (Journal of Korean Asspcoiation of Oral and Maxillifacual Surgeons 1987198713 1 217217 ~ P233 Lee Young-seok), antimicrobial effect on periodontal pathogens and bad breath-causing agents (Journal of the Korean) Academy of Dental Health 1998 22 3 P205 ~ P214 Moon Hyuk-su), The Journal of Korean Society of Anesthesiologist 1996 31 5 P634 ~ P639 Shinchiman, Restoration of skin barrier function (J Invest Dermatol. 1997 Jul; 109 (1): 84-90.Denda M), skin wound healing enhancing effect (Int J Oral Maxillofac Surg. 1988 Aug; 17 (4): 275-6.Bjorlin G, Nilsson IM.) A Comparative Study of Bleeding in Goat Treated with Anticoagulant (Journal of Korean Asspcoiation of Oral and Maxillifacual Surgeons, 1987, # 13, # 1, P207, P216, Se., Invest Clin. 1998 Jun; 39 (2): 77- 83.Spanish Bernardoni-Socorro C) has been studied. It was. In the patent document related to Tranexamsan, a pre-formed gel sheet (Domestic Application Publication No. 1020027000213), a sheet-like device (Domestic Application Publication No. 1020027000208), a transdermal absorbent using polymer nanoparticles, and an external preparation composition containing the same (Domestic Application Publication) No. 1020010019869), cleaning products for skin and hair in which skin protection active ingredients are deposited (National Application Publication No. 1020007011848), preparation method of sustained-release microspheres by the multiple emulsion method (Domestic Application Publication No. 1020000036178), traneck Samsan derivatives and skin external preparations containing them (Domestic Application Publication No. 1019947000952).

최근, 환경 문제의 대두로 인해 기존의 유기물을 이용한 추출 방법을 대체하는 새로운 추출 방법이 개발되고 있다. 이러한 방법 중 잔류물질의 독성을 최대한 낮추어 인체에 적용가능한 추출 방법로서, 초임계 유체 기술을 천연물 추출에 적용하는 방법이 시도되고 있다. 초임계 유체는 일반적으로 임계온도와 임계압력 이상에서 존재하는 유체로, 기체와 액체의 중간적인 성격에 기인한 낮은 점도와 높은 물질전달능력을 가지므로, 이를 응용하여 추출 정제에 이용되어 왔다. 대표적인 초임계 유체로는 이산화탄소를 들 수 있으며, 이는 낮은 임계온도와 압력에서 무독성의 환경친화성 등의 장점을 가지므로 많이 이용되고 있다(우슬중 β-ecdysone의 초임계추출법(SFE)과 용매추출법의 비교, Journal of the Korean society agricultural chemistry and biotechmology Vol. 44(3) pp.197-201, 2001, 심재환, 초임계추출과 형광유도체를 이용한 HPLC에서의 Quinclorac의 토양중 잔류분석, Journal of the Korean agricultural chemistry and biotechnology Vol.40(5) pp.442-446, 1997, 김용환, 초임계 추출법을 이용한 은행잎 중의 Phenol 성 물질의 추출, 생약학회지 Vol.25 No.1 [1994] 85-86, 허훈).Recently, due to the rise of environmental problems, a new extraction method is being developed to replace the existing extraction method using organic materials. Among these methods, a method of applying supercritical fluid technology to natural product extraction has been tried as an extraction method applicable to the human body by minimizing the toxicity of residual materials as much as possible. Supercritical fluids generally exist above critical temperatures and pressures, and have a low viscosity and high mass transfer ability due to the intermediate nature of gases and liquids. Representative supercritical fluids include carbon dioxide, which are widely used because they have advantages such as nontoxic environmental friendliness at low critical temperatures and pressures (supercritical extraction (SFE) and solvent extraction of β-ecdysone in the dew) , Journal of the Korean Society of Agricultural Chemistry and Biotechmology Vol. 44 (3) pp.197-201, 2001, Shim Jae-Hwan, Soil Residue Analysis of Quinclorac in HPLC by Supercritical Extraction and Fluorescent Inductor, Journal of the Korean Agricultural chemistry and biotechnology Vol.40 (5) pp.442-446, 1997, Yong-hwan Kim, Extraction of Phenol Compounds from Ginkgo Biloba Leaves by Supercritical Extraction, Journal of Pharmacognosy Vol.25 No.1 [1994] 85-86, Hur Hoon) .

본 출원인들은, 효과적인 주름방지 및 미백효과를 갖는 화장료를 얻기 위하여, 초임계 유체추출을 통해 보다 유효한 생리활성 성분이 추출된 상황버섯 초임계 유체추출물을 기본으로 각종 물질의 혼합을 시도한 바, 트라넥삼산을 배합하고, 니오좀으로 안정화함으로써, 유효성분의 상가(相加)효과 이상의 상승효과가 얻어짐을 알아내어 본 발명을 완성하게 되었다.Applicants have tried to mix various substances based on the situation mushroom supercritical fluid extract from which more effective physiologically active ingredients were extracted through supercritical fluid extraction in order to obtain a cosmetic having an effective anti-wrinkle and whitening effect. By blending samsan and stabilizing with niosomes, it was found that a synergistic effect beyond the additive effect of the active ingredient was obtained and completed the present invention.

따라서, 본 발명은 주름방지, 미백효과가 매우 우수하고 피부에 대한 활성이극대화된, 트라넥삼산 및 상황버섯 초임계 추출물을 함유하는 화장료를 얻는 것을 목적으로 한다.Therefore, an object of the present invention is to obtain a cosmetic containing tranexamic acid and super mushrooms supercritical extract, which is excellent in anti-wrinkle, whitening effect and maximized on the skin.

상기 목적을 달성하기 위하여 본 발명에 따르면, 트라넥삼산 및 상황버섯 초임계 추출물 함유 니오좀을 조성물 총중량에 대하여 0.01~20.0 중량% 함유하는 것을 특징으로 하는, 트라넥삼산 및 상황버섯 초임계 추출물 함유 니오좀을 함유하는 화장료 조성물이 제공된다.In order to achieve the above object, according to the present invention, characterized in that it contains 0.01 ~ 20.0% by weight relative to the total weight of the composition of the tranexamic acid and mushroom mushroom supercritical extract, containing the tranexamic acid and mushroom mushroom supercritical A cosmetic composition containing niosomes is provided.

이하 본 발명에 대하여 상세하게 설명한다.Hereinafter, the present invention will be described in detail.

본 발명의 상황버섯으로는, 소나무 비늘 버섯과의 진흙버섯속에 속하는 모든 상황버섯을 사용할 수 있다. 자연산 상황버섯을 사용하는 것이 바람직하고, 한국 내에 자생하는 자연산 상황 버섯을 사용하는 것이 특히 바람직하다.As a situation mushroom of this invention, all the situation mushroom which belongs to the mud mushroom genus with pine-scale mushroom can be used. It is preferable to use wild mushrooms, and it is particularly preferable to use wild mushrooms native to Korea.

이러한 상황버섯으로 초임계 추출물을 제조한다.Supercritical extract is prepared from these situational mushrooms.

초임계 추출물을 제조하기 위해서는, 먼저 상황버섯을 건조시킨 후 분쇄하여 상황버섯 분말을 제조한다.In order to prepare a supercritical extract, first the dried mushrooms are dried and then ground to prepare a mushroom mushroom powder.

추출용매로는, 이소프로필알콜, 프로필렌글리콜, 부틸렌글리콜 등의 다가 알콜류를 사용할 수 있으며, 1,3-부틸렌글리콜과 에탄올을 같은 질량비로 혼합한 후 교반하여 단일상이 되도록 하고 이를 공용매로 사용하는 것이 바람직하다.As the extraction solvent, polyhydric alcohols such as isopropyl alcohol, propylene glycol, butylene glycol, and the like can be used, and 1,3-butylene glycol and ethanol are mixed in the same mass ratio, followed by stirring to form a single phase and co-solvent. It is preferable to use as.

본 발명에 사용되는 초임계 유체 추출은 이산화탄소를 이용한 통상적인 방법으로 실시할 수 있으며, 구체적으로 다음과 같이 실시하는 것이 바람직하다.Supercritical fluid extraction used in the present invention can be carried out by a conventional method using carbon dioxide, specifically, it is preferably carried out as follows.

분쇄된 버섯과 공용매를 혼합하여 교반한다. 혼합비율은 분쇄된 버섯과 공용매를 1:2.5~6.5의 질량비이며, 바람직하게는 1:4의 질량비로 사용하는 것이 수율 면에서 가장 우수하다. 이어서, 이 혼합물을 초임계 추출조에 투입하고, 고압용 기체펌프를 이용하여 추출조에 이산화탄소를 공급한 후 압력을 높인다. 이어서, 추출조 내부의 온도를 40℃ 까지 승온시키고 이를 유지시킨다. 그리고나서, 이산화탄소를 추출조에 연속적으로 공급하면서, 출구 쪽에 부착된 압력조절기를 이용하여 추출물을 방출시킨다. 압력조절기의 온도를 조절하여, 방출물의 압력 및 온도강하로 인해 이산화탄소가 고체 드라이아이스로 전이되어 최종 출구쪽의 튜브가 막히는 현상을 방지한다. 이 온도는 60℃ 정도가 바람직하다. 방출된 추출물은 상압으로 감압되어 이산화탄소와 버섯 추출물이 분리되며, 이산화탄소는 대기로 방출되고 버섯 추출물은 회수된다. 추출물의 수율을 높이기 위해 상기 과정을 수회 반복할 수 있다.The ground mushroom and cosolvent are mixed and stirred. The mixing ratio is the mass ratio of the pulverized mushroom and the cosolvent is 1: 2.5 ~ 6.5, preferably using a mass ratio of 1: 4 is the best in terms of yield. Subsequently, the mixture is introduced into a supercritical extraction tank, and carbon dioxide is supplied to the extraction tank using a high pressure gas pump to increase the pressure. Then, the temperature inside the extraction tank is raised to 40 ° C. and maintained therein. Then, while continuously supplying carbon dioxide to the extraction tank, the extract is released using a pressure regulator attached to the outlet side. By controlling the temperature of the pressure regulator, the pressure and temperature drop of the discharge prevent carbon dioxide from transferring to solid dry ice and clogging the tube at the final outlet. As for this temperature, about 60 degreeC is preferable. The released extract is decompressed to atmospheric pressure to separate carbon dioxide and mushroom extract, carbon dioxide is released into the atmosphere and the mushroom extract is recovered. The process may be repeated several times to increase the yield of the extract.

트라넥삼산은 그대로 사용하거나, 1,3-부틸렌글리콜, 에탄올 등의 용매 또는 이의 혼합 용매에 용해시켜 사용할 수 있다. 그 중에서도, 에탄올과 1,3-부틸렌글리콜의 동량 혼합액을 사용하는 것이 바람직하다.Tranexamic acid can be used as it is, or can be used, melt | dissolving in solvents, such as 1, 3- butylene glycol and ethanol, or a mixed solvent thereof. Especially, it is preferable to use the same amount liquid mixture of ethanol and 1, 3- butylene glycol.

이어서, 상황버섯 추출물과 트라넥삼산을 혼합한다. 혼합비는 1:0.1~10.0가 바람직하고, 1:0.5~1.5가 더 바람직하며, 1:1이 가장 바람직하다. 트라넥삼산을 용액으로 사용하는 경우, 트라넥삼산 용액 중의 트라넥삼산의 비율을 상기와 같이 한다.Subsequently, the mushroom extract and tranesamic acid are mixed. The mixing ratio is preferably 1: 0.1 to 10.0, more preferably 1: 0.5 to 1.5, and most preferably 1: 1. In the case of using tranexamic acid as a solution, the ratio of tranexamic acid in the tranexamic acid solution is as described above.

상기 트라넥삼산 및 상황버섯 초임계 추출물을 안정화시키기 위한 니오좀으로는, 피부침투가 용이하고 수용성 성분을 과량 내포할 수 있으며 크기 10~50nm인,폐쇄된 이중층 구조를 갖도록 제조된 니오좀을 사용할 수 있다.As niosomes for stabilizing the tranexamic acid and the situation mushroom supercritical extract, it is easy to penetrate the skin, can contain excessive water-soluble components and the size of 10 ~ 50nm, niosome prepared to have a closed double layer structure to use Can be.

상기 니오좀 안에, 트라넥삼산 및 상황버섯 초임계 추출물을 내포시키기 위해서는, 니오좀의 구성성분을 가온하여 균일하게 혼합, 용해시켜 니오좀을 얻고, 여기에 트라넥삼산 및 상황버섯 초임계 추출물의 혼합물을 넣고, 이 혼합물을 고압유화장치(Microfludizer)에 통과시킨다.In order to contain the tranexamic acid and the situation mushroom supercritical extract in the niosomes, the components of the niosomes are heated and uniformly mixed and dissolved to obtain a niobium, wherein the extract of the tranexamic acid and the situation mushroom supercritical Add the mixture and pass the mixture through a Microfludizer.

상기 공정을 통해, 니오좀의 폐쇄된 이중층 구조 안에 유효성분인 트라넥삼산 및 상황버섯 초임계 추출물이 들어가 효과적으로 안정화됨으로써, 트라넥삼산 및 상황버섯 초임계 추출물의 효과가 극대화될 수 있다.Through the above process, by effectively stabilizing into the closed bilayer structure of niosome, the active ingredients of the tranexamic acid and situation mushroom supercritical extract, the effect of the tranexamic acid and situation mushroom supercritical extract can be maximized.

트라넥삼산 및 상황버섯 초임계 추출물은, 이를 함유하는 니오좀의 총중량에 대하여 0.001~15중량%의 양으로 포함되는 것이 바람직하고, 1~15중량% 포함되는 것이 특히 바람직하며, 5.0중량% 포함되는 것이 가장 바람직하다. 상기 함량 0.001 중량% 미만 함유 시에는 그 효과가 미미하며, 15 중량% 초과 시에는 그 함유량에 따른 상승작용이 미비하므로 상기 함량이 가장 바람직하다. 이 때, 트라넥삼산을 용액 상태로 사용하는 경우, 트라넥삼산 용액 중에 함유된 트라넥삼산과 상황버섯 초임계 추출물의 혼합물을 니오좀에 대해 상기 함량으로 포함시킨다.Tranexamic acid and super mushroom mushroom supercritical extract is preferably included in an amount of 0.001 to 15% by weight, particularly preferably 1 to 15% by weight, based on the total weight of niosomes containing the same, including 5.0% by weight. Most preferably. When the content is less than 0.001% by weight, the effect is insignificant, and when the content is more than 15% by weight, the synergy is not sufficient. At this time, when using the tranexamic acid in a solution state, a mixture of the tranexamic acid and the situation mushroom supercritical extract contained in the tranexamic acid solution is included in the above content for niosomes.

상기와 같이 제조된, 본 발명에 따른 트라넥삼산 및 상황버섯 초임계 추출물 함유 니오좀은, 화장수, 영양화장수, 영양크림, 에센스, 팩, 클렌징크림, 클렌징폼, 클렌징워터, 마사지 크림 등의 피부탄력, 주름개선 및 미백 관련 화장료에 첨가할 수 있으며, 조성물 총 중량에 대하여 0.01~20.0 중량%로 첨가하는 것이 바람직하다. 0.01 중량% 미만이면 효능이 지나치게 미미하고, 20.0 중량% 초과이면 화장료로서의 사용감이 떨어져 로션 등의 묽은 제품에는 사용하기에 부적합하다.Prepared as described above, niosome containing tranexamic acid and superficial mushroom supercritical extract according to the present invention, skin, such as lotion, nourishing longevity, nutrition cream, essence, pack, cleansing cream, cleansing foam, cleansing water, massage cream It can be added to the elasticity, wrinkle improvement and whitening-related cosmetics, it is preferred to add 0.01 to 20.0% by weight based on the total weight of the composition. If it is less than 0.01% by weight, the efficacy is too small, and if it is more than 20.0% by weight, the feeling of use as a cosmetic is poor, which is not suitable for use in thin products such as lotions.

이하 실시예 및 비교예, 제조예, 시험예는 본 발명을 더욱 상세하게 설명하기 위한 것으로, 본 발명의 권리 범위가 이들에 의해 제한되는 것은 아니다.The following Examples, Comparative Examples, Preparation Examples, and Test Examples are provided to explain the present invention in more detail, and the scope of the present invention is not limited thereto.

(실시예)(Example)

(자연산 상황버섯 초임계 추출물의 제조)(Preparation of natural situation mushroom supercritical extract)

자연산 상황버섯으로서, 한반도 지역에서 자생한 목질 진흙버섯(P. linteus)과 낙엽진흙버섯(P. pini)을 햇빛이 쪼이지 않는 서늘한 곳에서 중량의 변화가 없을 때까지 건조시킨 후, 동량 혼합하여 기계적인 방법으로 직경 1cm 이하의 크기로 분쇄하였다. 또한, 1,3-부틸렌글리콜과 에탄올을 같은 질량비율로 혼합한 후 교반시켜 단일상의 공용매를 제조하였다.As a natural mushroom, P. linteus and P. pini, native to the Korean Peninsula, are dried in a cool place without sunlight and mixed in the same amount. It was ground to a size of 1 cm in diameter or less by a mechanical method. In addition, 1,3-butylene glycol and ethanol were mixed in the same mass ratio and stirred to prepare a single-phase cosolvent.

분쇄된 버섯과 공용매를 1:4의 질량비로 혼합하여 30분간 교반시킨 후, 버섯과 공용매 혼합물을 내부 용적 1.5ℓ의 초임계 추출조에 투입하고 추출조를 밀봉하였다. 고압용 기체펌프를 이용하여 추출조에 이산화탄소를 공급하고 압력을 높인 뒤, 추출조의 압력이 300기압에 달하면 이산화탄소의 공급을 중단하였다.The mixed mushroom and cosolvent were mixed at a mass ratio of 1: 4 and stirred for 30 minutes, and then the mushroom and cosolvent mixture was put into a supercritical extraction tank having an internal volume of 1.5 L and the extraction tank was sealed. After supplying carbon dioxide to the extraction tank and increasing the pressure by using a high-pressure gas pump, the supply of carbon dioxide was stopped when the pressure of the extraction tank reached 300 atm.

PID 온도제어기를 이용하여 추출조 외부를 감싸고 있는 열선을 이용하여 추출조 내부의 온도를 0.5 /min 속도로 40℃ 까지 승온시켰다. 승온으로 인한 추출조의 압력은 추출조의 출구에 부착된 압력조절기를 이용하여 이산화탄소를 일부 배출하며 압력을 300기압으로 유지시켰다. 또한, 추출조의 온도와 압력을 40℃, 300기압으로 30분간 유지시켰다.The temperature inside the extraction tank was raised to 40 ° C. at a rate of 0.5 / min using a heating wire wrapped outside the extraction tank using a PID temperature controller. The pressure of the extraction tank due to the elevated temperature was partially discharged by the pressure regulator attached to the outlet of the extraction tank and maintained at 300 atm. In addition, the temperature and pressure of the extraction tank were kept at 40 ° C and 300 atmospheres for 30 minutes.

고압용 기체 펌프를 재가동하여 12ℓ/min의 유량으로 이산화탄소를 추출조에연속적으로 공급하였다. 동시에 출구쪽에 부착된 압력조절기를 이용하여 추출물 을 방출시키되, 압력조절기의 온도를 60℃로 유지시켰다. 방출된 추출물은 상압으로 감압되어 이산화탄소와 버섯 추출물이 분리되었고 이산화탄소는 대기로 방출되었다. 분리된 버섯 추출물을 유리 포집기를 이용하여 회수하였다. 상기 공정 중, 추출조 내부의 온도를 0.5 ℃/min 속도로 40℃ 까지 승온시키는 공정으로부터 분리된 버섯 추출물을 회수하는 공정까지를 수회 반복하여 10시간 동안 수행 후, 추출을 종료하고, 얻어진 추출물을 시료(이후 시료 S1라 함)로 사용하였다.The high pressure gas pump was restarted and carbon dioxide was continuously supplied to the extraction tank at a flow rate of 12 l / min. At the same time, the extract was released using a pressure regulator attached to the outlet, while maintaining the temperature of the pressure regulator at 60 ° C. The released extract was decompressed to atmospheric pressure to separate carbon dioxide and mushroom extract and carbon dioxide was released into the atmosphere. The separated mushroom extracts were recovered using a glass collector. During the above process, the process of recovering the separated mushroom extract from the step of raising the temperature inside the extraction tank to 40 ° C. at a rate of 0.5 ° C./min was repeated several times for 10 hours, and then the extraction was terminated. It was used as a sample (hereinafter referred to as sample S1).

(트라넥삼산 용액의 제조)(Preparation of Tranexamic Acid Solution)

에탄올과 1.3-부틸렌글리콜의 동량 혼합액 및 트라넥삼산을 중량비 1:1로 혼합하고, 실온에서 2시간 교반하여 용해시켜 시료(이후 시료 S2라 함)로 사용하였다.The same mixture of ethanol and 1.3-butylene glycol and tranexamic acid were mixed at a weight ratio of 1: 1, and stirred at room temperature for 2 hours to dissolve and used as a sample (hereinafter referred to as sample S2).

(트라넥삼산 용액 및 상황버섯 초임계 추출물의 혼합물 제조)(Preparation of a mixture of Tranexamic acid solution and supercritical mushroom supercritical extract)

상기 상황버섯 초임계 추출물(S1) 및 트라넥삼산 용액(S2)을 혼합하되, 상황버섯 초임계 추출물과 트라넥삼산 용액 중의 트라넥삼산의 중량비가 1:1이 되도록 혼합하였다. 이를 실온에서 2시간동안 교반하여 용해시켜 시료(이후 시료 S3이라 함)로 사용하였다.The supernatant mushroom supercritical extract (S1) and the tranexamic acid solution (S2) were mixed, but the weight ratio of the supernatant mushroom supercritical extract and the tranexamic acid in the tranexamic acid solution was mixed to be 1: 1. It was stirred for 2 hours at room temperature to dissolve and used as a sample (hereinafter referred to as sample S3).

(자연산 상황버섯 초임계 추출물 함유 니오좀의 제조)(Preparation of Niosome Containing Natural Situation Mushroom Supercritical Extract)

하기 표 1 조성의 A상을 95℃까지 가온하여 균일하게 혼합, 용해시켜 니오좀을 얻고, 이를 40℃까지 냉각시킨 후 B상을 넣고 혼합하였다. A와 B의 혼합물을 1000bar의 압력 조건하에서 고압유화장치에 3회 통과시켜 상황버섯 초임계 추출물함유 니오좀(이후 시료 S4라 함)을 얻었다.The phase A composition of Table 1 was heated to 95 ° C., mixed and dissolved uniformly to obtain niobium, which was cooled to 40 ° C., followed by mixing with phase B. A mixture of A and B was passed through a high pressure emulsifier three times under a pressure of 1000 bar to obtain niobium containing a situation mushroom supercritical extract (hereinafter referred to as sample S4).

성분ingredient 중량%weight% AA 페닐트리메치콘Phenyltrimethicone 55 글리세린glycerin 55 사이클로펜타실록산Cyclopentasiloxane 2020 베타-시토스테롤Beta-sitosterol 33 콜레스테롤cholesterol 33 메칠파라벤Methylparaben 0.20.2 콜레스-24/세테스-24Coles-24 / Setes-24 33 하이드로제네이티드레시친Hydrogenated Dressin 1One 디이에이-세틸포스페이트Die-cetylphosphate 0.40.4 디소듐이디티에이Disodium ID 0.010.01 부틸레이티드-하이드록시톨루엔Butylated-hydroxytoluene 0.050.05 토코페릴아세테이트Tocopheryl Acetate 0.50.5 프로필렌글라이콜Propylene glycol 적량Quantity BB 시료 S1Sample S1 1010 system 100100

(트라넥삼산 함유 니오좀의 제조)(Preparation of Trinexamic Acid-containing Niosome)

표 1의 B상으로 시료 S2를 첨가하되, 니오좀 내의 트라넥삼산 함량이 10 중량%가 되도록 첨가하는 것을 제외하고는, S4의 제조방법과 동일하게 트라넥삼산 함유 니오좀(이후 시료 S5라 함)을 제조하였다.Sample S2 is added to phase B of Table 1, except that the content of tranexamic acid in niosomes is 10% by weight, except for adding tranexamic acid-containing niosomes (Sample S5). Was prepared).

(트라넥삼산 및 상황버섯 초임계 추출물의 혼합물 함유 니오좀의 제조)Preparation of Niosomes Containing a Mixture of Tranexamic Acid and Sacral Mushroom Supercritical Extraction

표 1의 B상으로 시료 S3를 첨가하되, 니오좀 내의 트라넥삼산과 상황버섯 초임계 추출물이 10 중량%가 되도록 첨가하는 것을 제외하고는, S4의 제조방법과 동일하게 트라넥삼산 및 상황버섯 초임계 추출물 함유 니오좀(이후 시료 S6라 함)을 제조하였다.Sample S3 is added to phase B of Table 1, except that tranexamic acid and supernatant mushroom supercritical extract in niosomes are added in an amount of 10% by weight. A niosome containing supercritical extract (hereinafter referred to as sample S6) was prepared.

(시험예 1)(Test Example 1)

멜라닌 생성량 억제 시험Melanin Production Inhibition Test

인체 조직으로부터 분리한 멜라닌 세포를 1차 배양하여 2계대 후, 60㎜ 배양 접시에서 RPMI 1640 배지를 사용하여 2×104세포/배양접시의 농도로 배양하였다. 세포가 접시에 부착한 것을 확인한 후, 하기 표 2a, 2b와 같이 시료 S1, S2, S3, S4, S5 및 S6를 농도별로 각각 첨가하였다. 첨가 3일 후, PBS로 3회 세척해 낸 후, 트립신-EDTA로 세포를 떼어내어 2×105세포를 일정하게 분배하였다. 여기에 100㎕의 1N NaOH 용액을 넣고 37℃에서 12시간 처리하여 세포를 완전히 용해시켰다. 세포가 완전히 용해된 시료 500㎕에 대하여 490nm에서 흡광도를 측정하였다. 또한 추출물 무처리구를 대조구로 하여 흡광도를 측정하였다.Melanocytes isolated from human tissues were primaryly cultured and passaged two times, and then cultured in 60 mm culture dishes at a concentration of 2 × 10 4 cells / culture plate using RPMI 1640 medium. After confirming that the cells adhered to the dish, samples S1, S2, S3, S4, S5 and S6 were added for each concentration as shown in Tables 2a and 2b. Three days after the addition, the cells were washed three times with PBS, and then cells were detached with trypsin-EDTA to uniformly distribute 2 × 10 5 cells. 100 μl of 1N NaOH solution was added thereto and treated at 37 ° C. for 12 hours to completely lyse the cells. Absorbance was measured at 490 nm for 500 μl of cells in which cells were completely lysed. In addition, absorbance was measured using the extract-free treatment as a control.

표준 지표로, 합성 멜라닌(M8601, 시그마사제) 10㎎을 1N NaOH 10㎖에 용해시켜 모용액(1㎎/㎖)을 제조한 후, 700㎍/㎖, 300㎍/㎖, 100㎍/㎖, 70㎍/㎖, 30㎍/㎖, 10㎍/㎖, 7㎍/㎖, 3㎍/㎖, 1㎍/㎖, 0.1㎍/㎖ 희석액을 제조하여 490nm에서 흡광도를 측정하였다.As a standard indicator, 10 mg of synthetic melanin (M8601, manufactured by Sigma) was dissolved in 10 ml of 1N NaOH to prepare a mother solution (1 mg / ml), followed by 700 µg / ml, 300 µg / ml, 100 µg / ml, Dilutions of 70 µg / ml, 30 µg / ml, 10 µg / ml, 7 µg / ml, 3 µg / ml, 1 µg / ml and 0.1 µg / ml were prepared and the absorbance was measured at 490 nm.

측정한 흡광도를 사용하여 하기 식에 따라 멜라닌 감소량을 계산하였다.Using the measured absorbance, the amount of melanin reduction was calculated according to the following equation.

그 결과를 하기 표 2a, 2b에 나타내었다.The results are shown in Tables 2a and 2b.

상기 표 2a, 2b에서, 본 발명에 따른 트라넥삼산 및 상황버섯 초임계 추출물 함유 니오좀은 멜라닌 감소 효과가 우수함을 알 수 있다. 또한, 트라넥삼산 및 상황버섯 초임계 추출물 함유 니오좀은 0.01~20중량%로 사용하는 것이 바람직함을 알수 있다.In Tables 2a and 2b, it can be seen that the niorosomal containing tranexamic acid and the situation mushroom supercritical extract according to the present invention has an excellent melanin reduction effect. In addition, it can be seen that it is preferable to use trinemic acid and niobium containing supernatant mushroom supernatant at 0.01 to 20% by weight.

(시험예 2)(Test Example 2)

콜라겐 생합성 효과Collagen Biosynthesis Effect

T-75 플라스크에 배양되어진 섬유아세포를 PBS로 2∼3회 세척하고, 트립신을 이용하여 부착된 세포를 떨어뜨린 후, 1500rpm에서 5분간 원심분리(Heraeus; Labofuge 400R)하여 세포를 모았다. 원심분리 후 상층액은 버리고, 모아진 세포에 10㎖의 DMEM(10% FBS)을 첨가하여 고르게 섞었다. 혈구계수기를 이용하여 세포수를 측정하여 104ea/웰 정도의 세포를 96웰의 각 웰에 200㎕씩 분주하였다. 37℃, 5% CO2에서 배양하면서 웰 면적의 약 50%정도의 세포가 자라면 새로운 DMEM(FBS10%)으로 교환해 주면서, 시료 S1, S2, S3, S4, S5 및 S6를 하기 표 3a, 3b와 같이 농도별로 각각 첨가하여 세포를 배양하였다.Fibroblasts incubated in T-75 flasks were washed 2-3 times with PBS, the adhered cells were dropped using trypsin, and the cells were collected by centrifugation (Heraeus; Labofuge 400R) at 1500 rpm for 5 minutes. After centrifugation, the supernatant was discarded, and 10 ml of DMEM (10% FBS) was added to the collected cells and mixed evenly. Cell counts were measured using a hemocytometer, and 200 μl of cells of about 96 ea / well were dispensed into each well of 96 wells. When cells at about 50% of the well area were grown while incubating at 37 ° C. and 5% CO 2 , the samples S1, S2, S3, S4, S5 and S6 were exchanged with new DMEM (FBS10%). Cells were cultured by adding each concentration as shown in 3b.

콜라겐 생합성 효과를 확인하기 위해 콜라겐 합성능 측정키트 (Procollagen Type-I C-peptide EIA kit (Takara, MK 101))를 사용하였다. 면역학적 방법을 이용한 측정법을 위하여 100㎕의 Ab-POD 컨쥬게이트 용액을 하나의 웰에 옮겨 분주하고 , 20㎕의 세포배양액 또는 표준용액을 첨가하였다. 호일로 96 웰 플레이트를 싸서 37℃에서 3시간 정도 배양하였다. 3시간 경과 후 각 웰에 들어있는 용액을 모두 제거하고 PBS로 4번정도 세척하였다. 세척 단계 후에 100㎕의 기질용액을 각 웰에 첨가하여 20∼30℃에서 15분간 배양하였다. 최종 단계로 반응종료 용액인 1N H2SO4를 100㎕ 첨가하여 부드럽게 혼합하였다. ELISA 판독기로 흡광도를 측정하여 그 결과를 사용하였다. 반응종료용액이 첨가되된 플레이트를 약 1시간 정도 실온에서 보관한 후 450nm에서 흡광도를 측정하였다.Collagen synthesis performance measurement kit (Procollagen Type-I C-peptide EIA kit (Takara, MK 101)) was used to confirm the collagen biosynthesis effect. For measurement using immunological methods, 100 μl of Ab-POD conjugate solution was transferred to one well and aliquoted, and 20 μl of cell culture or standard solution was added. A 96 well plate was wrapped in foil and incubated at 37 ° C. for about 3 hours. After 3 hours, all the solutions in each well were removed and washed 4 times with PBS. After the washing step, 100 μl of substrate solution was added to each well and incubated at 20-30 ° C. for 15 minutes. In the final step, 100 µl of 1N H 2 SO 4 , the reaction termination solution, was added and mixed gently. The absorbance was measured with an ELISA reader and the result was used. After the reaction solution was added, the plate was stored at room temperature for about 1 hour and absorbance was measured at 450 nm.

합성(%)를 하기 식에 따라 계산하여, 그 결과를 표 3a, 3b에 나타내었다.Synthesis (%) was calculated according to the following formula, and the results are shown in Tables 3a and 3b.

상기 표 3에서, 본 발명에 따른 트라넥삼산 및 상황버섯 초임계 추출물 함유 니오좀은 세포증식에 의한 콜라겐 생합성능이 우수함을 알 수 있다. 또한, 트라넥삼산 및 상황버섯 초임계 추출물 함유 니오좀은 0.01~20중량%로 사용하는 것이 바람직함을 알 수 있다.In the above Table 3, it can be seen that the nitric acid-containing trinexamic acid and the situation mushroom supercritical extract according to the present invention have excellent collagen biosynthesis by cell proliferation. In addition, it can be seen that it is preferable to use trinemic acid and niobium-containing mushroom supercritical extract at 0.01 to 20% by weight.

(제조예 1)(Manufacture example 1)

하기 표 4의 성분을 혼합하여 본 발명에 따른 화장료를 제조하였다.To prepare a cosmetics according to the invention by mixing the components of Table 4.

(비교제조예 1 내지 5)(Comparative Production Examples 1 to 5)

하기 표 4의 성분을 혼합하여 화장료를 제조하였다.To prepare a cosmetic by mixing the components of Table 4.

(시험예 3)(Test Example 3)

피부탄력 증진효과Skin elasticity enhancing effect

온도 22-24℃, 상대습도 55% 조건에서 20세 이상의 건강한 여성 30명을 6그룹으로 나누고, A그룹에는 제조예 1을, B그룹에는 비교제조예 1를, C그룹에는 비교제조예 2, D그룹에는 비교제조예 3을, E그룹에는 비교제조예 4를, F그룹에는 비교제조예 5를 각각 하기 표 5에 따라 제형화하여 눈가를 중심으로 12주간 도포(2회/일)한 후, 피부탄력측정기(Cutometer SEM 575, C+K Electronic Co., Germany)를 이용하여 피부탄력을 측정하였다.Thirty healthy women over the age of 20 were divided into six groups at a temperature of 22-24 ° C and a relative humidity of 55% .Preparation Example 1 in Group A, Comparative Production Example 1 in Group B, Comparative Production Example 2 in Group C, Comparative Preparation Example 3 in Group D, Comparative Preparation Example 4 in Group E, and Comparative Production Example 5 in Group F, respectively, were formulated according to Table 5 below, followed by 12 weeks of application (2 times / day) around the eyes. Skin elasticity was measured using a skin elasticity measuring instrument (Cutometer SEM 575, C + K Electronic Co., Germany).

실험결과는 하기 표 5에 피부탄력측정기의 각 시험 그룹별 평균값을 △R5값[R5(12주)-R5(0주)] 값으로 기재하였다. R5값은 실탄성계수를 나타내는 값으로 1에 가까워지면 보다 탄력도가 우수함을 나타낸다.The experimental results are described in Table 5 below as the average value of each test group of the skin elasticity measuring instrument as ΔR5 value [R5 (12 weeks) -R5 (0 weeks)]. The value of R5 represents the actual modulus of elasticity, and closer to 1 indicates that the elasticity is better.

피부탄력 증강효과(△R5)Skin elasticity enhancing effect (△ R5) 제조예 1Preparation Example 1 0.280.28 비교제조예 1Comparative Production Example 1 0.100.10 비교제조예 2Comparative Production Example 2 0.080.08 비교제조예 3Comparative Production Example 3 0.110.11 비교제조예 4Comparative Production Example 4 0.100.10 비교제조예 5Comparative Production Example 5 0.120.12

표 5에서, 상황버섯 초임계 추출물 및 트라넥삼산 함유 니오좀을 함유하는 제조예 1의 피부탄력증강효과는 비교제조예 1에 비해 35.71%, 비교제조예 2에 비해 28.57%, 비교제조예 3에 비해 39.29%, 비교제조예 4에 비해 35.71%, 비교제조예 5에 비해 42.85%증가했다.In Table 5, the skin elasticity-enhancing effect of Preparation Example 1 containing the situation mushroom supercritical extract and Tranexamic acid-containing niosomes was 35.71% compared to Comparative Preparation Example 1, 28.57% compared to Comparative Preparation Example 2, Comparative Preparation Example 3 Compared with Comparative Preparation Example 4, it was 39.29%, 35.71% and 42.85%, respectively.

따라서, 본 발명에 따른 상황버섯 초임계 추출물 및 트라넥삼산 함유 니오좀을 함유하는 화장료 조성물은, 상황버섯 초임계 추출물 및 트라넥삼산을 혼합하여 니오좀으로 안정화시킴으로써, 니오좀으로 안정화되지 않은 상태의 상황버섯 초임계 추출물 및 트라넥삼산이나, 상황버섯 초임계 추출물 및 트라넥삼산 각각을 함유하는 니오좀을 사용한 경우에 비해, 훨씬 뛰어난 피부탄력증강효과가 얻어짐을 알수 있었다.Therefore, the cosmetic composition containing the supernatant mushroom supercritical extract and tranexamic acid-containing niosomes according to the present invention is mixed with the supernatant mushroom supercritical extract and tranexamic acid and stabilized with niosomes, which are not stabilized with niosomes. Compared to the case of using the niobium containing supernatant extract and tranexamic acid or supernatant mushroom and tranexamic acid, respectively, the skin elasticity enhancing effect was obtained.

(실험예 4)Experimental Example 4

멜라닌 생성 억제에 따른 미백효과Whitening effect by inhibiting melanin production

기미, 주근깨에 대한 피부 외용제로서의 효과를 알아보기 위하여, 이중맹검법에 따라 웰제어실험(Well Control Test)을 실시하고, 그 결과에 대해 색차계(Minolta社, Chromameter CR-300)를 이용하여 L값(명도)을 산출하였다.In order to investigate the effect of external skin on blemishes and freckles, Well Control Test was conducted according to the double blind method, and the results were analyzed using a color difference meter (Minolta, Chromameter CR-300). The value (brightness) was calculated.

실험방법으로는, 팔 위쪽 부위에 자외선을 0.88J/㎠로 1회/1일씩 3회 조사한 후, 제조예 1 및 비교제조예 1 내지 5를 각각 2회/일, 30일간 도포하였다. 도포 전, 후의 L값에 따른 미백효과를 하기 식에 따라 계산하였다.As an experimental method, ultraviolet rays were irradiated to 0.88J / cm <2> three times once a day for 1 day, and manufacture example 1 and comparative manufacture examples 1-5 were applied twice a day for 30 days, respectively. The whitening effect according to L value before and after application was calculated according to the following formula.

그 결과를 하기 표 6에 나타내었다.The results are shown in Table 6 below.

미백효과 L(%)Whitening Effect L (%) 제조예 1Preparation Example 1 9494 비교제조예 1Comparative Production Example 1 3232 비교제조예 2Comparative Production Example 2 2828 비교제조예 3Comparative Production Example 3 4545 비교제조예 4Comparative Production Example 4 3838 비교제조예 5Comparative Production Example 5 3939

상기 표 6에서, 본 발명에 따른 상황버섯 초임계 추출물 및 트라넥삼산 함유 니오좀을 함유하는 화장료 조성물은, 상황버섯 초임계 추출물 및 트라넥삼산을 혼합하여 니오좀으로 안정화시킴으로써, 니오좀으로 안정화되지 않은 상태의 상황버섯 초임계 추출물 및 트라넥삼산이나, 상황버섯 초임계 추출물 및 트라넥삼산 각각을 함유하는 니오좀을 사용한 경우에 비해, 훨씬 효과적으로 피부의 흑화현상을 방지할 수 있을 뿐 아니라 피부 얼룩을 제거할 수 있는 미백효과가 얻어짐을 알 수 있었다.In Table 6, the cosmetic composition containing the situation mushroom supercritical extract and tranexamic acid-containing niosome according to the present invention, by stabilizing niosome by mixing the situation mushroom supercritical extract and tranexamic acid, niosome It is much more effective in preventing skin blackening as compared to the case of using niobium containing supernatant extract and tranexamic acid, or supersomnia extract and tranexamic acid, respectively. It was found that a whitening effect was obtained to remove stains.

(실험예 5)Experimental Example 5

제형의 안정성 시험Formulation Stability Test

상기 제조예 1 및 비교제조예 1 내지 5를 각각 45℃로 일정하게 유지되는 항온조에서 불투명 초자 용기에 담아 12주동안 보관한 시료, 4℃로 일정하게 유지되는 완전히 차광된 냉장고 내에서 불투명 초자 용기에 담아 12주 동안 보관한 시료, -5℃에서 37℃를 순환하는 순환 챔버에 12주동안 보관한 시료의 분리 정도 및 변색 정도를 비교 측정하였다.Samples stored in an opaque glass container for 12 weeks in a constant temperature bath at constant temperature maintained at 45 ℃, respectively, Preparation Example 1 and Comparative Production Examples 1 to 5, the opaque glass container in a completely shaded refrigerator maintained at 4 ℃ constant The separation and discoloration of the samples stored for 12 weeks and samples stored for 12 weeks in a circulation chamber circulating at -5 ℃ to 37 ℃ was measured.

그 결과를 하기 표 7에 나타내었다.The results are shown in Table 7 below.

이때 제품 분리 및 변색 정도를 다음의 6등급으로 분류하여 평가하였다.At this time, the degree of product separation and discoloration were evaluated by classifying into the following six grades.

제품 변색 평가 기준 :Product discoloration evaluation criteria:

0: 변화 없음 1: 극히 조금 분리(변색)0: no change 1: very little separation (discoloration)

2: 조금 분리(변색) 3: 조금 심하게 분리(변색)2: Separate slightly (discolored) 3: Separate slightly (discolored)

4: 심하게 분리(변색) 5: 극히 심하게 분리(변색)4: severely separated (discolored) 5: extremely severely separated (discolored)

온도Temperature 제조예 1Preparation Example 1 비교제조예 1Comparative Production Example 1 비교제조예 2Comparative Production Example 2 비교제조예 3Comparative Production Example 3 비교제조예 4Comparative Production Example 4 비교제조예 5Comparative Production Example 5 45℃45 ℃ 00 22 00 00 00 1One 4℃4 ℃ 00 00 00 00 00 00 -10~-50℃순환-10 ~ -50 ℃ 00 22 1One 00 00 22

상기 표 7에서, 본 발명에 따른 제조예 1은 모든 시험조건에서 안정함을 유지하였으나, 비교제조예 1는 45℃, 순환 시험에서 변색이나 분리 증상이, 비교제조예 2는 순환시험에서 극히 조금 분리 및 변색이 나타나 불안정하였으며, 비교제조예 3은 45℃에서 변색 및 순환 시험에서 분리가 나타났다. 따라서, 트라넥삼산 및 상황버섯 초임계 추출물을 안정화하지 않고 직접 사용한 비교제조예 1, 비교제조예 2, 비교제조예 5는 각각 45℃, 순환시험에서 약간의 변색 및 분리가 일어나 추출물이 불안정함을 알 수 있었다.In Table 7, Preparation Example 1 according to the present invention was maintained stable in all the test conditions, Comparative Preparation Example 1 is 45 ℃, discoloration or separation symptoms in the circulation test, Comparative Preparation Example 2 is very little in the circulation test Dissociation and discoloration were unstable, and Comparative Example 3 showed dissociation in discoloration and circulation tests at 45 ° C. Accordingly, Comparative Preparation Example 1, Comparative Preparation Example 2, and Comparative Preparation Example 5, which were used directly without stabilizing the tranesamic acid and the situation mushroom supercritical extract, respectively, had a slight discoloration and separation in the circulating test, resulting in unstable extracts. And it was found.

(제조예 2)(Manufacture example 2)

화장수(스킨 로션)Lotion (skin lotion)

(제조예 3)(Manufacture example 3)

영양화장수(로션)Nourishing Cosmetic Lotion

(제조예 4)(Manufacture example 4)

농축화장수(에센스)Concentrated Cosmetic Water (Essence)

(제조예 5)(Manufacture example 5)

영양크림Nutrition Cream

(제조예 6)(Manufacture example 6)

마사지크림Massage cream

(제조예 7)(Manufacture example 7)

클린징 크림Cleansing cream

(제조예 8)(Manufacture example 8)

pack

본 발명에 따르면, 콜라겐 생합성 및 피부탄력증진에 따른 주름방지효과와, 멜라닌 생성감소에 따른 미백효과가 매우 탁월할 뿐 아니라, 안정성 및 안전성이 뛰어나고, 피부투과율도 우수한 트라넥삼산 및 상황버섯 초임계 추출물 함유 화장료 조성물을 얻을 수 있다.According to the present invention, the anti-wrinkle effect due to collagen biosynthesis and skin elasticity and the whitening effect due to reduced melanin production are not only excellent, but also excellent in stability and safety, and excellent skin permeability. An extract-containing cosmetic composition can be obtained.

Claims (2)

트라넥삼산 및 상황버섯 초임계 추출물 함유 니오좀을 조성물 총중량에 대하여 0.01~20.0 중량% 함유하는 것을 특징으로 하는, 트라넥삼산 및 상황버섯 초임계 추출물 함유 니오좀을 함유하는 화장료 조성물.A cosmetic composition comprising tranexamic acid and supernatant mushroom supercritical extract, containing 0.01-20.0% by weight, based on total weight of the composition. 제 1항에 있어서,The method of claim 1, 상기 트라넥삼산 및 상황버섯 초임계 추출물 함유 니오좀은, 트라넥삼산 및 상황버섯 초임계 추출물의 중량비 1:0.1~10.0 혼합물이 니오좀의 총중량에 대해 0.001~15 중량%의 양으로 함유되어 있는 것을 특징으로 하는 화장료 조성물.The niomesome containing the tranexamic acid and the situation mushroom supercritical extract, the weight ratio of the tranexamic acid and the situation mushroom supercritical extract 1: 0.1 ~ 10.0 mixture is contained in an amount of 0.001 ~ 15% by weight relative to the total weight of the niosome Cosmetic composition, characterized in that.
KR1020030034367A 2003-05-29 2003-05-29 Cosmetic composition containing niosome with tranexamic acid and supercritical fluid extract of phellinus linteus KR20040102766A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020030034367A KR20040102766A (en) 2003-05-29 2003-05-29 Cosmetic composition containing niosome with tranexamic acid and supercritical fluid extract of phellinus linteus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020030034367A KR20040102766A (en) 2003-05-29 2003-05-29 Cosmetic composition containing niosome with tranexamic acid and supercritical fluid extract of phellinus linteus

Publications (1)

Publication Number Publication Date
KR20040102766A true KR20040102766A (en) 2004-12-08

Family

ID=37378978

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020030034367A KR20040102766A (en) 2003-05-29 2003-05-29 Cosmetic composition containing niosome with tranexamic acid and supercritical fluid extract of phellinus linteus

Country Status (1)

Country Link
KR (1) KR20040102766A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102389391A (en) * 2011-08-18 2012-03-28 桑黃美人(株) Natual cosmetic composition for beautifying and whitening
KR102177196B1 (en) 2020-02-14 2020-11-11 주식회사 바이오뷰텍 Nanoparticle multi-layered lamellar niosomes which is formed by nanoparticlation after being formed large niosomes in a supercritical state and cosmetic composition thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102389391A (en) * 2011-08-18 2012-03-28 桑黃美人(株) Natual cosmetic composition for beautifying and whitening
KR102177196B1 (en) 2020-02-14 2020-11-11 주식회사 바이오뷰텍 Nanoparticle multi-layered lamellar niosomes which is formed by nanoparticlation after being formed large niosomes in a supercritical state and cosmetic composition thereof

Similar Documents

Publication Publication Date Title
JP2003081749A (en) Skin care preparation
EP2113245A2 (en) Substances capable of potentiating laminin 5 productivity in epidermal cells and their use
KR101574558B1 (en) Cosmetic composition containing ginsenoside Rd, Rb2 and Bambusae Caulis in Taeniam extracts
JP2004067590A (en) Female sex hormone production promoter and skin preparation for external use containing the same
CN109091422B (en) Cosmetic containing Pleurotus citrinopileatus extract and its preparation method
EP4193986A1 (en) Anti-aging and antioxidant cosmetic composition containing broccoli exosomes as active ingredient and functional cosmetics comprising same
KR100954695B1 (en) Cosmetic Composition Comprising the Extract of Abelliophyllum distichum as active Ingredient
KR102058445B1 (en) Cosmetics composition with Extract of Sparassis crispa Wulf. ex Fr.
JP3648730B2 (en) Skin cosmetics
KR102441009B1 (en) Methods for extracting compound from ginseng, ginseng extract comprising the compound and composition for enhancing skin barrier comprising the same
JPH06336422A (en) External agent for skin
KR100545044B1 (en) Cosmetics composition containing medicine herbs complex extract stabilized with nano-liposome
KR102455132B1 (en) Cosmetic composition containing lemon myrtle extract and its manufacturing method
KR101149711B1 (en) Whitening cosmetic composition containing Hippophae rhamnoides extract, low molecular weight fucoidan and niacin amide, and the method for preparing thereof
KR101111177B1 (en) A herb medicine extracts for improvement of skin anti-aging and a cosmetic composition containing the same
JP2002249438A (en) Age retardant for living organism
KR101775485B1 (en) Cosmetic composition containing fermentative extract of Spatholobus suberectus Dunn as active ingredient
KR20190048935A (en) Cosmetic composition comprising extract of red onion fermented by aureobasidium pullulans
KR20220102236A (en) A cosmetic composition for blocking fine dust and anti-aging
KR20040102766A (en) Cosmetic composition containing niosome with tranexamic acid and supercritical fluid extract of phellinus linteus
JP2000256175A (en) Cosmetic composition
JP2004107269A (en) Carbonylation inhibiting agent for protein, skin care preparation for external use, and method
JP3946418B2 (en) Melanin production inhibitor
KR20040101709A (en) Cosmetic composition containing camellia japonica extract stabilized with nanoliposome
KR100695996B1 (en) Niosome containing natural phellinus linteus extract and cosmetic composition containing it

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application